Linzagolix With and Without Hormonal Add-Back Therapy for the Treatment of Symptomatic Uterine Fibroids: Two Randomized, Placebo-Controlled, Phase 3 Trials

Linzagolix With and Without Hormonal Add-Back Therapy for the Treatment of Symptomatic Uterine Fibroids: Two Randomized, Placebo-Controlled, Phase 3 Trials Editorial Material

publication date

December 1, 2022

webpage

Web of Science

published in

OBSTETRICAL & GYNECOLOGICAL SURVEY Journal

start page

741

end page

742

volume

77

issue

12